BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23199527)

  • 21. Loss of heterozygosity on chromosome arm 11q in lung carcinoids.
    Petzmann S; Ullmann R; Klemen H; Renner H; Popper HH
    Hum Pathol; 2001 Mar; 32(3):333-8. PubMed ID: 11274644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in the expression of p53, KLF4, and p21 in neuroendocrine lung tumors.
    Naranjo Gómez JM; Bernal JF; Arranz PG; Fernández SL; Roman JJ
    Arch Pathol Lab Med; 2014 Jul; 138(7):936-42. PubMed ID: 24978920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary metastatic renal metastatic carcinoid tumor in a young male patient: a contribution to the differential diagnosis of neuroendocrine tumors].
    Gross ML; Berger I
    Pathologe; 2007 Jul; 28(4):285-90. PubMed ID: 16645706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric neuroendocrine neoplasms: tumour clonality and malignancy-associated large X-chromosomal deletions.
    D'Adda T; Candidus S; Denk H; Bordi C; Höfler H
    J Pathol; 1999 Nov; 189(3):394-401. PubMed ID: 10547602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].
    Correia Sda S; Pinto C; Bernardo J
    Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [CGH findings in neuroendocrine tumours of the lung].
    Johnen G; Krismann M; Jaworska M; Müller KM
    Pathologe; 2003 Jul; 24(4):303-7. PubMed ID: 14513278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential distribution of the neuron-associated class III beta-tubulin in neuroendocrine lung tumors.
    Katsetos CD; Kontogeorgos G; Geddes JF; Herman MM; Tsimara-Papastamatiou H; Yu Y; Sakkas LI; Tsokos M; Patchefsky AS; Ehya H; Cooper HS; Provencio J; Spano AJ; Frankfurter A
    Arch Pathol Lab Med; 2000 Apr; 124(4):535-44. PubMed ID: 10747310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Histologic Grading and Ki-67 Index in Predicting Outcomes in Pulmonary Carcinoid Tumors.
    Dermawan JKT; Farver CF
    Am J Surg Pathol; 2020 Feb; 44(2):224-231. PubMed ID: 31490236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary Renal Well-Differentiated Neuroendocrine Tumors: Analyis of Six Cases from a Tertiary Care Center in North India with Review of Literature.
    Kumari N; Verma R; Agrawal V; Singh UP
    Int J Surg Pathol; 2023 Sep; 31(6):982-992. PubMed ID: 35903907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biphasic alveolosquamoid renal carcinoma: a histomorphological, immunohistochemical, molecular genetic, and ultrastructural study of a distinctive morphologic variant of renal cell carcinoma.
    Petersson F; Bulimbasic S; Hes O; Slavik P; Martínek P; Michal M; Gomolčáková B; Hora M; Damjanov I
    Ann Diagn Pathol; 2012 Dec; 16(6):459-69. PubMed ID: 23036259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statistical evaluation of 2001 carcinoid cases with metastases, collected from literature: a comparative study between ordinary carcinoids and atypical varieties.
    Soga J
    J Exp Clin Cancer Res; 1998 Mar; 17(1):3-12. PubMed ID: 9646227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinctive renal cell tumor simulating atrophic kidney with 2 types of microcalcifications. Report of 3 cases.
    Hes O; de Souza TG; Pivovarcikova K; Grossmann P; Martinek P; Kuroda N; Kacerovska D; Svajdler M; Straka L; Petersson F; Hora M; Michal M
    Ann Diagn Pathol; 2014 Apr; 18(2):82-8. PubMed ID: 24456861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian mucinous carcinoids including some with a carcinomatous component: a report of 17 cases.
    Baker PM; Oliva E; Young RH; Talerman A; Scully RE
    Am J Surg Pathol; 2001 May; 25(5):557-68. PubMed ID: 11342766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic changes in the spectrum of neuroendocrine lung tumors.
    Onuki N; Wistuba II; Travis WD; Virmani AK; Yashima K; Brambilla E; Hasleton P; Gazdar AF
    Cancer; 1999 Feb; 85(3):600-7. PubMed ID: 10091733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carcinoid Tumors of Digestive Organs: a Clinicopathologic Study of 13 Cases.
    Terada T
    Gastroenterology Res; 2009 Feb; 2(1):35-37. PubMed ID: 27956948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
    Langfort R; Rudziński P; Burakowska B
    Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistologic analysis of gastrointestinal and pulmonary carcinoid tumors.
    Al-Khafaji B; Noffsinger AE; Miller MA; DeVoe G; Stemmermann GN; Fenoglio-Preiser C
    Hum Pathol; 1998 Sep; 29(9):992-9. PubMed ID: 9744317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kidney carcinoid tumor: Histological, immunohistochemical and ultrastructural features.
    Gu X; Cheng M; Herrera GA
    Ultrastruct Pathol; 2018; 42(1):18-22. PubMed ID: 29192809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical treatment of a rare primary renal carcinoid tumor with liver metastasis.
    Gedaly R; Jeon H; Johnston TD; McHugh PP; Rowland RG; Ranjan D
    World J Surg Oncol; 2008 Apr; 6():41. PubMed ID: 18430248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.